Cargando…
Corrigendum: Photothermal therapeutic application of gold nanorods-porphyrin-trastuzumab complexes in HER2-positive breast cancer
Autores principales: | Kang, Xinmei, Guo, Ximing, Niu, Xingjian, An, Weiwei, Li, Suhan, Liu, Zhaoliang, Yang, Yue, Wang, Na, Jiang, Qicheng, Yan, Caichuan, Wang, Hui, Zhang, Qingyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388076/ https://www.ncbi.nlm.nih.gov/pubmed/28398298 http://dx.doi.org/10.1038/srep44519 |
Ejemplares similares
-
Photothermal therapeutic application of gold nanorods-porphyrin-trastuzumab complexes in HER2-positive breast cancer
por: Kang, Xinmei, et al.
Publicado: (2017) -
Corrigendum: High-throughput screening of metal-porphyrin-like graphenes for selective capture of carbon dioxide
por: Bae, Hyeonhu, et al.
Publicado: (2017) -
Corrigendum: Photothermally triggered actuation of hybrid materials as a new platform for in vitro cell manipulation
por: Sutton, Amy, et al.
Publicado: (2017) -
Corrections to “Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer”
por: Baselga, J., et al.
Publicado: (2019) -
Corrigendum: nanoSQUID operation using kinetic rather than magnetic induction
por: McCaughan, Adam N., et al.
Publicado: (2017)